Who owns VIRACTA THERAPEUTICS INC?
- Ticker: VIRX
- CUSIP Number: 92765f108
Tip: Access positions for across all investors
Analyze quarterly positions in Viracta Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Viracta Therapeutics stock
Who bought or sold VIRACTA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
BVF | 3.6M | $2.1M | 0% | Dec 2023 |
|
Citadel Advisors | 1.5M | $872k | 1% | Dec 2023 |
|
Vanguard Group | 1.2M | $662k | 1% | Dec 2023 |
|
Samsara BioCapital | 690k | $393k | 0% | Dec 2023 |
|
Laurion Capital Management | 563k | $321k | -19% | Dec 2023 |
|
MAI Wealth Advisors | 356k | $203k | -11% | Dec 2023 |
|
BlackRock | 307k | $319k | -33% | Sep 2023 |
|
Aisling Capital Management | 289k | $165k | 0% | Dec 2023 |
|
Geode Capital Management | 253k | $263k | 13% | Sep 2023 |
|
UBS Group | 169k | $96k | 259389% | Dec 2023 |
|
Renaissance Technologies | 148k | $154k | 10% | Sep 2023 |
|
Acadian Asset Management | 97k | $99k | -42% | Sep 2023 |
|
Bridgeway Capital Management | 74k | $77k | -41% | Sep 2023 |
|
State Street Corporation | 66k | $69k | 0% | Sep 2023 |
|
Ensign Peak Advisors | 63k | $66k | 0% | Sep 2023 |
|
Morgan Stanley | 60k | $63k | 2% | Sep 2023 |
|
Northern Trust | 37k | $38k | -5% | Sep 2023 |
|
Squarepoint Ops | 36k | $21k | 100% | Dec 2023 |
|
Virtu Financial | 27k | $16k | 100% | Dec 2023 |
|
United Bank | 25k | $14k | 26% | Dec 2023 |
|
Two Sigma Securities | 16k | $8.9k | 100% | Dec 2023 |
|
HoyleCohen | 14k | $8.0k | 0% | Dec 2023 |
|
Trust Co Of Toledo Na | 12k | $7.0k | -63% | Dec 2023 |
|
XTX Topco | 12k | $13k | 100% | Sep 2023 |
|
Royal Bank of Canada | 11k | $0 | 600% | Dec 2023 |
|
Integrys Wealth Advisors | 10k | $5.9k | 100% | Dec 2023 |
|
Bank of America Corporation | 8.1k | $4.6k | -33% | Dec 2023 |
|
Bourgeon Capital Management | 7.5k | $4.3k | 0% | Dec 2023 |
|
Planning Capital Management Corp | 7.3k | $4.1k | 100% | Dec 2023 |
|
Tower Research Capital | 5.1k | $5.1k | 0% | Sep 2023 |
|
RP Management | 3.7k | $3.8k | 0% | Sep 2023 |
|
IAG Wealth Partners | 3.0k | $1.7k | 0% | Dec 2023 |
|
Barclays | 2.7k | $2.0k | 0% | Dec 2023 |
|
Jpmorgan Chase & Co | 721.00 | $410.970000 | 0% | Dec 2023 |
|
Wells Fargo & Company | 382.00 | $216.708600 | 3% | Dec 2023 |
|
Indiana Trust & Investment Management | 200.00 | $114.000000 | 0% | Dec 2023 |
|
Goss Wealth Management | 14.00 | $14.999600 | 100% | Sep 2023 |
|
Parallel Advisors | 8.00 | $5.000000 | 0% | Dec 2023 |
|
Addison Advisors | 4.00 | $3.000000 | 0% | Dec 2023 |
|
Private Ocean | 3.00 | $2.000100 | 0% | Dec 2023 |
|
Qube Research & Technologies | 2.00 | $2.000000 | 100% | Sep 2023 |
|
Who sold out of Viracta Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Dimensional Fund Advisors | Sep 2023 | 53k | $55k |
Millennium Management | Sep 2023 | 37k | $38k |
Susquehanna International | Jun 2023 | 17k | $24k |
Charles Schwab Investment Management | Sep 2023 | 12k | $13k |
Bailard | Sep 2023 | 12k | $12k |
Simplex Trading | Sep 2023 | 1.1k | $1.0k |
Nbc Securities | Sep 2023 | 700.00 | $0 |
Group One Trading | Jun 2023 | 100.00 | $141.000000 |
FMR | Jun 2023 | 8.00 | $12.000000 |